Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1921 1
1927 1
1978 1
1981 1
1984 1
1988 2
1991 1
1993 1
1994 1
1995 1
1996 3
1997 2
1998 3
1999 8
2000 8
2001 4
2002 10
2003 10
2004 5
2005 11
2006 6
2007 2
2008 5
2009 2
2011 4
2012 6
2013 3
2014 5
2015 4
2016 1
2017 1
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 9621281

107 results
Results by year
Filters applied: . Clear all
Page 1
The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy.
Kuan CJ, al-Douahji M, Shankland SJ. Kuan CJ, et al. J Am Soc Nephrol. 1998 Jun;9(6):986-93. J Am Soc Nephrol. 1998. PMID: 9621281 Free article.
The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.
Daniel C, Pippin J, Shankland SJ, Hugo C. Daniel C, et al. Lab Invest. 2004 May;84(5):588-96. doi: 10.1038/labinvest.3700078. Lab Invest. 2004. PMID: 15064772 Free article.
Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS, Makino H. Baba M, et al. J Am Soc Nephrol. 2005 Nov;16(11):3222-34. doi: 10.1681/ASN.2004110915. Epub 2005 Sep 21. J Am Soc Nephrol. 2005. PMID: 16177004 Free article.
The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
Al-Douahji M, Brugarolas J, Brown PA, Stehman-Breen CO, Alpers CE, Shankland SJ. Al-Douahji M, et al. Kidney Int. 1999 Nov;56(5):1691-9. doi: 10.1046/j.1523-1755.1999.00728.x. Kidney Int. 1999. PMID: 10571777 Free article.
Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
Zahner G, Wolf G, Ayoub M, Reinking R, Panzer U, Shankland SJ, Stahl RA. Zahner G, et al. J Biol Chem. 2002 Mar 22;277(12):9763-71. doi: 10.1074/jbc.M106307200. Epub 2001 Dec 26. J Biol Chem. 2002. PMID: 11756433 Free article.
Role of growth arrest-specific gene 6 in diabetic nephropathy.
Arai H, Nagai K, Doi T. Arai H, et al. Vitam Horm. 2008;78:375-92. doi: 10.1016/S0083-6729(07)00015-5. Vitam Horm. 2008. PMID: 18374201 Review.
Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, Iehara N, Fukatsu A, Yanagita M, Nakano T, Ishimoto Y, Kita T, Doi T, Arai H. Nagai K, et al. Kidney Int. 2005 Aug;68(2):552-61. doi: 10.1111/j.1523-1755.2005.00433.x. Kidney Int. 2005. PMID: 16014032 Free article.
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R. Agarwal C, et al. Oncogene. 2003 Nov 13;22(51):8271-82. doi: 10.1038/sj.onc.1207158. Oncogene. 2003. PMID: 14614451
Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.
Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ. Shankland SJ, et al. Kidney Int. 1996 Oct;50(4):1230-9. doi: 10.1038/ki.1996.432. Kidney Int. 1996. PMID: 8887282 Free article.
Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Kim SI, Han DC, Lee HB. Kim SI, et al. J Am Soc Nephrol. 2000 Jan;11(1):80-7. J Am Soc Nephrol. 2000. PMID: 10616843 Free article.
107 results
Jump to page
Feedback